Clinical trials

Research into an blepharitis ointment has failed to achieve the primary endpoint in its Phase III trial, prompting the company...

Recent conferences have offered fresh clinical insights into repeated low-level red-light (RLRL) therapy in myopia management. At this year’s Asia-Pacific...

Perfuse Therapeutics, Inc., a US biopharmaceutical company pioneering transformational therapies to treat ischemia-induced ocular diseases, has announced positive results from...

The European Commission (EC) has granted a label extension in the European Union (EU) for Eylea 8mg (aflibercept 8mg, 114.3mg/ml...

ForSight Robotics, an Israeli company developing ophthalmic robotic surgery platforms, has secured US$125 million (AU$191m) in funding to continue its...

Canadian ophthalmic technology company Ocumetics Technology Corp has announced that it is undertaking what it claims is the first-in-human (FIH)...

Researchers in the US are developing an experimental drug to slow or halt damage to the eye from diabetic retinopathy....

The first Australian data into the efficacy of repeated low-level red-light (RLRL) has been published in what is shaping to...

Researchers in China have developed contact lenses that could allow humans to see in the dark using infrared vision. The...

Research involving Australian patients has returned positive results for a device intended for the treatment of chronic ocular surface pain...